HIA
HALO icon

HFM Investment Advisors’s Halozyme HALO Stock Holding History

HFM Investment Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02K Buy
13
+6
+86% +$409 ﹤0.01% 724
2026
Q1 		$452 Sell
7
-18
-72% -$1.27K ﹤0.01% 714
2025
Q4 		$1.68K Buy
25
+18
+257% +$1.21K ﹤0.01% 326
2025
Q3 		$513 Hold
7
– – ﹤0.01% 649
2025
Q2 		$364 Buy
7
+4
+133% +$228 ﹤0.01% 774
2025
Q1 		$192 Buy
+3
New +$174 ﹤0.01% 645

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

HFM Investment Advisors's HALO Position: Q2 2026 in Review

HFM Investment Advisors increased its Halozyme (HALO) stake by 86% in Q2 2026, buying an estimated $409 and bringing the position to 13 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #724.

HFM Investment Advisors first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.68K in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • HFM Investment Advisors held 13 shares of Halozyme worth $1.02K as of Q2 2026.
  • HFM Investment Advisors bought 6 Halozyme shares in Q2 2026, an estimated $409.
  • Halozyme made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #724 holding.
  • HFM Investment Advisors first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • HFM Investment Advisors's Halozyme position peaked at $1.68K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.